EVGN News
Evogene Schedules Third Quarter 2026 Financial Results Release
Evogene Schedules Third Quarter 2026 Financial Results Release Evogene Schedules Third Quarter 2026 Financial Results ReleasePR NewswireREHOVOT, Israel, Nov. 5, 2026 Zoom conference call scheduled for November 19, 2026, 9:00 AM ETREHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq...
PR Newswire
Evogene Schedules Third Quarter 2026 Financial Results Release
Evogene Schedules Third Quarter 2026 Financial Results Release Evogene Schedules Third Quarter 2026 Financial Results ReleasePR NewswireREHOVOT, Israel, Nov. 5, 2026 Zoom conference call scheduled for November 19, 2026, 9:00 AM ETREHOVOT, Israel, Nov. 5, 2026 /PRNewswire/ -- Evogene Ltd. (Nasdaq...
PR Newswire
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program
Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery Program Evogene Announces Acute Graft-Versus-Host Disease (aGVHD) as the Target Indication for Its Internal AI-Driven Drug Discovery ProgramPR NewswireREHOVOT, Israel, Oct...
PR Newswire
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in SpainPR NewswireREHOVOT, Israel, Oct. 26, 2026 Company to Attend BIO-Europe in Cologne, Germany, and...
PR Newswire
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeILPR NewswireREHOVOT, Israel, Oct. 20, 2026 The roadshow...
PR Newswire
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of DirectorsPR NewswireREHOVOT, Israel, Oct. 6, 2026REHOVOT, Israel, Oct. 6...
PR Newswire
Evogene Gets 180-day Nasdaq Extension To Regain Compliance
(RTTNews) - Israeli computational chemistry company Evogene Ltd. (EVGN), announced on Wednesday that it has received an additional 180 days from Nasdaq to regain compliance with the minimum $1 bid price requirement...
Nasdaq News: Markets
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price CompliancePR NewswireREHOVOT, Israel, Sept. 30, 2026REHOVOT, Israel, Sept. 30, 2026 /PRNewswire/ -- Evogene Ltd...
PR Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers
Evogene (NASDAQ:EVGN) shares increased by 75.0% to $0.72 during Tuesday's after-market session. The company's market cap stands at $4.5 million.
AIxCrypto Hldgs (NASDAQ:AIXC) stock moved upwards byread more...
Benzinga
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward PR Newswire REHOVOT, Israel, Aug. 31, 2026 Company urges shareholders to...
PR Newswire
Evogene (EVGN) Q2 2026 Earnings Call Transcript
Evogene (EVGN) Q2 2026 Earnings Call Transcript...
Yahoo! Finance: News